Pass4sure 9A0-901 dumps | Killexams.com 9A0-901 real questions | http://bigdiscountsales.com/

9A0-901 glance Lite 1.1 Mobile Developer(R) Certification

Study sheperd Prepared by Killexams.com ADOBE Dumps Experts


Killexams.com 9A0-901 Dumps and real Questions

100% real Questions - Exam Pass Guarantee with tall Marks - Just Memorize the Answers



9A0-901 exam Dumps Source : Flash Lite 1.1 Mobile Developer(R) Certification

Test Code : 9A0-901
Test designation : Flash Lite 1.1 Mobile Developer(R) Certification
Vendor designation : ADOBE
exam questions : 108 real Questions

I need real test questions modern-day 9A0-901 examination.
well, I did it and i cannot accord with it. I may want to in no course fill passed the 9A0-901 with out your help. My marks became so extreme i was amazed at my performance. Its just due to you. thanks very much!!!


9A0-901 examination prep got to be this smooth.
I passed the 9A0-901 exam. It was the first time I used killexams.com for my preparation, so I didnt know what to expect. So, I got a pleasant surprise as killexams.com has stunned me and totally passed my expectations. The exam simulator/practice tests work great, and the questions are valid. By sound I addupto that they are real exam questions, and I got many of them on my actual exam. Very reliable, and I was left with majestic impressions. I would not waver to recommend killexams.com to my colleagues.


What is needed to recognize at and pass 9A0-901 examination?
The killexams.com material is straightforward to understand and enough to prepare for the 9A0-901 exam. No one-of-a-kind solemnize material I used at the side of the Dumps. My heartfelt course to you for developing such an distinctly powerful, simple material for the difficult exam. I in no course notion I might likewise want to pass this exam without hardship without any tries. You human beings made it capture location. I responded 76 questions maximum successfully in the actual exam. Thank you for supplying me an revolutionary product.


I sense very assured via getting ready 9A0-901 real exam questions.
Me and my roommate were residing collectively for a long term and weve numerous disagreements and arguments concerning diverse matters but if there is one component that both people accord on it is the truth that this killexams.com is the top class one at the net to employ in case you want to skip your 9A0-901 . Both people used it and had been very tickled with the outcome that they were given. I turned into able to execute well in my 9A0-901 check and my marks fill been truely super. Thank you for the guidance.


amazed to peer 9A0-901 real test questions!
The nice preparation I fill ever skilled. I took many 9A0-901 certification exams, but 9A0-901 turned out to be the easiest one thanks to killexams.com. I even fill lately observed this internet site and wish I knew about it a few years ago. Would fill stored me numerous sleepless nights and gray hair! The 9A0-901 exam isnt always an simple one, especially its synchronous model. But the 9A0-901 Q and A consists of the todays questions, every day updates, and these are really birthright and sound questions. I am convinced that is real antecedent I were given most of them at some point of my exam. I got an remarkable marks and thank killexams.com to making 9A0-901 exam stress-unfastened.


You just need a weekend for 9A0-901 examination prep with those dumps.
As I long gone thru the road, I made heads flip and every unique individual that walked beyond me changed into lookingat me. The reason of my unexpected reputation turned into that I had gotten the pleasant marks in my Cisco test and every person turned into shocked at it. i used to be astonished too but I knew how such an success changed intopossible for me without killexams.com QAs and that became everything because of the preparatory instructions that I took in thiskillexams.com. They were faultless adequate to execute me execute so appropriate.


Feel confident by preparing 9A0-901 dumps.
That is to inform that I passed 9A0-901 exam the other day. This killexams.com questions solutions and exam simulator changed into very useful, and i dont assume i would fill finished it without it, with best per week of training. The 9A0-901 questions are real, and that is exactly what I saw in the test center. Moreover, this prep corresponds with everything of the key issues of the 9A0-901 exam, so i was truely organized for a few questions that fill been barely special from what killexams.com provided, however at the identical subject matter. But, I passed 9A0-901 and satisfiedapproximately it.


I need actual test questions of 9A0-901 exam.
Im scripting this because I need yo suppose course to you. i fill efficiently cleared 9A0-901 exam with 96%. The test questions and answers chain made with the useful resource of your crew is first rate. It not simplest offers a real sense of a web exam however each offerseach question with precise explananation in a simple language which is simple to apprehend. I am extra than tickled that I made the birthright covet through purchasing for your check series.


surprised to observe 9A0-901 brand current dumps!
At ultimate, my score 90% was extra than choice. At the point when the exam 9A0-901 turned into handiest 1 week away, my making plans changed into in an indiscriminate situation. I expected that i would need to retake in the occasion of disappointment to pickup 80% marks. Taking after a partners recommendation, i purchased the exam questions from killexams.com and will capture a slight arrangement via commonly composed material.


making ready 9A0-901 examination with exam questions is be counted modern some hours now.
it is unbelievable smack for the 9A0-901 exam. With now not a total lot stuff available on line, Im joyous I were givenkillexams.com. The questions/solutions are just top class. With killexams.com, the exam become very easy, extraordinary.


ADOBE glance Lite 1.1 Mobile

cellular glance apps pickup more suitable distribution, greater funds | killexams.com real Questions and Pass4sure dumps

In strengthen of this week’s cellular World Congress in Barcelona, Adobe is making a number of bulletins to motivate builders to construct purposes the employ of its glance and AIR systems. The largest announcements are a current distribution way for glance Lite (the cell version of Flash) and a brand current $10 million fund for the pile of glance and AIR apps.

mobile devices look to be the subsequent huge frontier for Adobe’s Flash, which powers a total lot of the media and functions on the internet, and AIR, which does the same for applications that work backyard the internet browser. more than a thousand million gadgets are estimated to fill shipped with glance Lite through the conclusion of this quarter, however Adobe has yet to execute glance as predominant within the cellular world because it is on incurious computer and desktop computer systems. That’s one of the most dreams of the Open screen mission spearheaded by means of Adobe, which is supposed to assuage builders execute glance and AIR purposes that work throughout many contraptions.

the brand current distribution comes in the benevolent of the Adobe glance Lite Distributable participant. Adobe says the participant makes it even more straightforward to pickup glance Lite and its purposes on your mobile. developers can now deliver their purposes without detain to determined cellular contraptions, and users can down load each the software and the latest version of glance Lite on the same time. The participant works with a few utility aggregators, including GetJar, Thumbplay, and Zed, and is launching in testing mode nowadays on windows mobile and Nokia S60 gadgets. That’s a serious development over the historical model of downloading glance Lite first, then downloading the utility.

Adobe and Nokia fill likewise created a $10 million Open pomp challenge fund to assist businesses that build applications that work on Nokia gadgets and employ glance or AIR. birthright here’s what they’re attempting to find: “purposes will be reviewed for a course inventive and compelling the user adventure is, how robust the software or planned implementation is, and how neatly it exploits the capabilities and lines of Nokia contraptions, Adobe Flash, and Adobe AIR.”

There’s nevertheless no precise note, however, on bringing glance to Apple’s iPhone, which has been a relentless supply of hypothesis for the previous 12 months. final November, Adobe Chief know-how Officer Kevin Lynch stated the trade has created an iPhone version of glance however is waiting for approval from Apple. meanwhile, Apple has been encouraging developers to create applications the usage of JavaScript as opposed to glance or Microsoft’s competing platform Silverlight. So Apple evidently isn’t embracing glance on the iPhone, but they don’t be alert of if it'll near the door completely.


Microsoft's License of Adobe glance Lite for mobile devices is first rate for patrons | killexams.com real Questions and Pass4sure dumps

No outcome found, try current key phrase!had licensed Adobe's glance Lite application in order that glance primarily based content might be able to be considered within internet Explorer on future models of Microsoft windows cell phones. whereas glance Lite itself d...

S60 5th edition Sees fb customer, glance Lite three.1 | killexams.com real Questions and Pass4sure dumps

cellphone users who personal a Symbian S60 fifth edition-powered handset fill now two reasons to fill a kindly time, as each a facebook application particularly developed for them and glance Lite three.1 are available, coming without detain from Adobe. the current facebook client will likewise be create on the Ovi rescue and comes as a web Runtime widget, while glance Lite may likewise be up to date to the newest version through the “App replace” utility.

What the current glance Lite 3.1 provides clients of S60 fifth version phones with comprises more suitable web searching (ninety one% of excellent 500 cyber web websites, says Adobe), glance 9 (AS2 only) support, local Connection / HTML text / GetURL_target / CSS support / WMode, H.264 guide, better video aid (smoothing, are seeking), enhanced recollection dealing with for images, MP3 streaming aid, assuage for hardware acceleration (Flash Lite 3.1 helps OpenVG 1.1 to enrich glance rendering performance on ready devices), and Linux Reference port.

The better allotment about the current edition of glance Lite seems to be the incontrovertible fact that it can be simply attach in and does not require a restart of the gadget. those that would want to enhance the glance efficiency of their device will most effectual should download and set up a 700k file, and they will be able to luxuriatein a leveraged internet adventure on their handset birthright away.

As for the facebook client for the OS, birthright here is how the application is described at Ovi store: “fb for Nokia S60 contact allows you to preserve up together with your chums correct at your fingertips. update your repute, observe what your friends are up to, upload photographs, check messages and search for mobilephone numbers in case you want them each time and anyplace. fb allows you to comment on your friend’s statuses, RSVP to smack invitations and authenticate or deny pal requests. The facebook for Nokia S60 brings facebook at once to your phone. If facebook is not purchasable for your machine, gladden assess Ovi save.”

folks that would like to are attempting out the brand current fb application can learn it as a free down load on Ovi store, which will likewise be accessed either from a laptop pc, by means of this hyperlink, or without detain from the mobile phone, here. the blokes from everything About Symbian already played around with the app and additionally published some shots with it, so that you can observe it at work here.


Whilst it is very difficult job to pick reliable exam questions / answers resources regarding review, reputation and validity because people pickup ripoff due to choosing incorrect service. Killexams. com execute it certain to provide its clients far better to their resources with respect to exam dumps update and validity. Most of other peoples ripoff report complaint clients approach to us for the brain dumps and pass their exams enjoyably and easily. They never compromise on their review, reputation and trait because killexams review, killexams reputation and killexams client self assurance is necessary to everything of us. Specially they manage killexams.com review, killexams.com reputation, killexams.com ripoff report complaint, killexams.com trust, killexams.com validity, killexams.com report and killexams.com scam. If perhaps you observe any bogus report posted by their competitor with the designation killexams ripoff report complaint internet, killexams.com ripoff report, killexams.com scam, killexams.com complaint or something like this, just preserve in intellect that there are always imperfect people damaging reputation of kindly services due to their benefits. There are a large number of satisfied customers that pass their exams using killexams.com brain dumps, killexams PDF questions, killexams drill questions, killexams exam simulator. Visit Killexams.com, their test questions and sample brain dumps, their exam simulator and you will definitely know that killexams.com is the best brain dumps site.

Back to Bootcamp Menu


650-474 brain dumps | 000-923 free pdf download | CITP cheat sheets | 2V0-731 braindumps | 000-789 brain dumps | C2080-470 VCE | HS330 mock exam | 000-992 dumps | 1Z0-860 drill exam | HP0-728 free pdf | HP0-823 questions answers | QIA free pdf | ST0-090 cram | HP0-553 real questions | 1Z1-050 questions and answers | 72-640 drill test | A2040-986 study guide | QQ0-200 dumps questions | ACMP-6.4 test prep | 9A0-040 exam prep |


Simply retain these 9A0-901 questions before you evaporate for test.
Simply smack their Questions answers and sense guaranteed around the 9A0-901 exam. You will pass your exam at tall marks or your cash back. They fill accumulated a database of 9A0-901 Dumps from actual test to fill the capacity to give you a prep to pickup prepared and pass 9A0-901 exam at the first attempt. Essentially introduce their Exam Simulator and prepare. You will pass the exam.

Are you searching for ADOBE 9A0-901 Dumps of real questions for the glance Lite 1.1 Mobile Developer(R) Certification test prep? they present most updated and trait 9A0-901 Dumps. Their comprehensive Dumps and study sheperd is what you need to pickup kindly marks in the exam. Detail is at http://killexams.com/pass4sure/exam-detail/9A0-901. they fill got compiled an information of 9A0-901 Dumps from actual tests to allow you to prepare and pass 9A0-901 exam on the first attempt. simply memorize their exam questions and relax. you will pass the test. killexams.com Discount Coupons and Promo Codes are as under; WC2017 : 60% Discount Coupon for everything exams on website PROF17 : 10% Discount Coupon for Orders larger than $69 DEAL17 : 15% Discount Coupon for Orders larger than $99 SEPSPECIAL : 10% Special Discount Coupon for everything Orders

killexams.com allows hundreds of thousands of candidates pass the tests and pickup their certifications. They fill thousands of a hit testimonials. Their dumps are reliable, affordable, updated and of truly best nice to conquer the difficulties of any IT certifications. killexams.com exam dumps are cutting-edge updated in noticeably outclass course on regular basis and material is released periodically. Latest killexams.com dumps are available in trying out centers with whom they are preserving their courting to pickup modern day cloth.

The killexams.com exam questions for 9A0-901 glance Lite 1.1 Mobile Developer(R) Certification exam is particularly based on two handy codecs, PDF and drill questions. PDF document carries everything of the exam questions, answers which makes your coaching less complicated. While the drill questions are the complimentary function inside the exam product. Which enables to self-determine your development. The assessment instrument additionally questions your vulnerable areas, in which you need to attach more efforts so that you can enhance everything of your concerns.

killexams.com advocate you to should try its free demo, you will solemnize the intuitive UI and likewise you will learn it very pass to personalize the instruction mode. But execute positive that, the actual 9A0-901 product has extra functions than the ordeal version. If, you are contented with its demo then you should purchase the real 9A0-901 exam product. Avail 3 months Free updates upon buy of 9A0-901 glance Lite 1.1 Mobile Developer(R) Certification Exam questions. killexams.com gives you three months loose update upon acquisition of 9A0-901 glance Lite 1.1 Mobile Developer(R) Certification exam questions. Their expert crew is constantly available at back quit who updates the content as and while required.

killexams.com Huge Discount Coupons and Promo Codes are as under;
WC2017 : 60% Discount Coupon for everything exams on internet site
PROF17 : 10% Discount Coupon for Orders greater than $69
DEAL17 : 15% Discount Coupon for Orders extra than $99
DECSPECIAL : 10% Special Discount Coupon for everything Orders


Since 1997, we have provided a high quality education to our community with an emphasis on academic excellence and strong personal values.


Killexams 000-M87 drill questions | Killexams OMG-OCUP-200 questions answers | Killexams 000-M34 braindumps | Killexams 820-427 test prep | Killexams 102-400 dumps questions | Killexams GB0-180 free pdf | Killexams HH0-130 exam prep | Killexams HP2-Z19 drill questions | Killexams P2060-001 study guide | Killexams 7141X dump | Killexams CAT-260 free pdf | Killexams ES0-005 real questions | Killexams 000-202 cheat sheets | Killexams 1Z0-881 test prep | Killexams 000-742 free pdf download | Killexams 000-635 exam prep | Killexams HP2-Z04 test questions | Killexams S90-19A brain dumps | Killexams 000-M37 braindumps | Killexams 000-799 exam questions |


Exam Simulator : Pass4sure 9A0-901 Exam Simulator

View Complete list of Killexams.com Brain dumps


Killexams HP0-449 VCE | Killexams BH0-010 brain dumps | Killexams LOT-912 braindumps | Killexams 310-044 pdf download | Killexams 98-369 drill questions | Killexams TB0-121 real questions | Killexams PEGACCA exam questions | Killexams 1Z0-807 braindumps | Killexams 1Z0-523 drill test | Killexams 000-529 braindumps | Killexams MD0-205 exam prep | Killexams S90-19A drill exam | Killexams 70-331 examcollection | Killexams 190-513 test prep | Killexams 700-410 cheat sheets | Killexams 500-451 free pdf | Killexams HP0-S43 sample test | Killexams 9A0-086 drill questions | Killexams CPP study guide | Killexams 500-275 drill test |


Flash Lite 1.1 Mobile Developer(R) Certification

Pass 4 positive 9A0-901 dumps | Killexams.com 9A0-901 real questions | http://bigdiscountsales.com/

Dell Technologies (DVMT) on Q1 2018 Results - Earnings convene Transcript | killexams.com real questions and Pass4sure dumps

No result found, try current keyword!Our ISG trade saw revenue growth in PowerEdge servers and strengthened their newer solutions, including all-flash arrays, hyperconverged systems ... shares of Class V common stock for a total of $1.1 ...

Align Technology, Inc. (ALGN) Q4 2018 Earnings Conference convene Transcript | killexams.com real questions and Pass4sure dumps

Image source: The Motley Fool.

Align Technology, Inc. (NASDAQ: ALGN)Q4 2018 Earnings Conference CallJan. 29, 2019, 4:30 p.m. ET

Greetings and welcome to the Align Technology Q4 Full-Year Earnings Call. At this time, everything participants are in a listen-only mode. A brief question-and-answer session will result the formal presentation. If anyone should require operator assistance during the conference, gladden press "*0" on your telephone keypad. As a reminder, this conference is being recorded.

I would now like to rotate the conference over to Shirley Stacy with Align. Thank you. gladden begin.

Good afternoon and thank you for joining us. I'm Shirley Stacy, Vice President of Corporate Communications and Investor Relations. Joining me for today's convene is Joe Hogan, President and CEO, and John Morici, CFO.

We issued fourth quarter and full-year 2018 monetary results today via Globe Newswire, which is available at their website at investor.aligntech.com. Today's conference convene is likewise being audio webcast and will be archived on their website for approximately 12 months. A telephone replay will be available today by approximately 5:30 p.m. Eastern time through 5:30 p.m. Eastern time on February 12. To access the telephone replay, domestic callers should dial 877-660-6853 with conference number 13685779#. International callers should dial 201-612-7415 with the same conference number.

As a reminder, the information that the presenters argue today will comprise forward-looking statements, including statements about Align's future events, product outlook, and the expected monetary results for the first quarter and full-year outlook for 2019. These forward-looking statements are only predictions and involve risks and uncertainties that are set forth in more detail in their most recent sporadic reports filed with the Securities and Exchange Commission. Actual results may vary significantly and Align expressly assumes no duty to update any forward-looking statement.

We fill posted historical monetary statements, including the corresponding reconciliations, and their fourth quarter and full-year 2018 conference convene slides on their website under "Quarterly Results." gladden mention to these files for more minute information.

With that, I'll rotate the convene over to Align Technology's President and CEO, Joe Hogan. Joe?

Joseph M. Hogan -- President and Chief Executive Officer

Thanks, Shirley. kindly afternoon and thanks for joining us. On their convene today, I'll provide some highlights from the fourth quarter and complete year, then briefly argue the performance of their two operating segments, limpid aligners and intraoral scanners. John will provide more detail on their monetary results, argue their outlook for the first quarter, and share their thoughts for 2019. Following that, I'll approach back and summarize a few key points and open up the convene to questions.

Our fourth quarter was a stalwart finish to a majestic year. Q4 revenues were better than expected, reflecting higher Invisalign ASPs and volume growth of 31% year-over-year, as well as another record quarter for iTero scanners, with revenue up 55% year-over-year. Q4 sequential growth was driven by a stalwart quarter for EMEA, with record growth for teens, as well as continued traction with Invisalign Lite and I Go.

Q4 operating margin of 22.6% reflects higher doctor training and manufacturing costs, as well as higher legal fees than anticipated, partially offset by sequential improvement in Invisalign ASPs. For the quarter, they trained a record 5,270 current doctors in Q4, which includes about 3,000 international doctors of which half were in EMEA and half were in APAC.

For the year, they achieved record revenues of nearly $2 billion and had over 1.2 million people start treatment with Invisalign limpid aligners for the first time, resulting in their sixth millionth Invisalign patient, a teenager from China. These results reflect record revenues and volumes for both Invisalign and iTero across customer channels and country markets and continued strength from teens, which grew 40%. The total number of teenagers treated with Invisalign this year was over 330,000, representing 27% of their volume.

Finally, in 2018, they trained a record number of current Invisalign doctors, nearly 20,000 worldwide, and for the first time, more than half of them were international doctors.

Now, let's rotate to the specifics around their fourth quarter results, starting with the Americas region. For the Americas region, Q4 Invisalign case volume increased 21.7% year-over-year and was down sequentially off of record Q3 volumes which benefited from stalwart uptake of promotions terminal quarter, predominantly by high-volume Invisalign doctors. On a sequential basis, Q4 reflects growth from the Americas GPs offset by Americas orthos, particularly high-volume doctors. Year-over-year growth for Q4 reflects continued adoption of Invisalign treatment from both orthodontist and GP channels, which were up 24.7% and 17.3% respectively. They likewise saw kindly growth from their DSO partners across both GPs and orthos, up nearly 50% year-over-year.

For the complete year, Invisalign volume for the Americas region was up 24.2% compared to 2017. Americas orthos were up 27.2% and Americas GP dentists were up 19.8%, the second highest annual growth rate for orthos and the highest annual growth rate for GPs in six years. For Q4, they trained a record 2,290 current Invisalign doctors in the Americas region, of which 1,725 were North American doctors and 565 were Latin American doctors. In total, they trained 7,885 current Invisalign doctors in the Americas in 2018, an enlarge of 19%.

For their international business, Q4 was a majestic quarter, with Invisalign case volume up 12.2% sequentially, driven by stalwart growth in the EMEA region offset Somewhat by seasonality in the Asia Pacific region. On a year-over-year basis, stalwart Invisalign volume growth of 45.3% reflects increased utilization and continued expansion of their customer base in both EMEA and the Asia Pacific region. In Q4, they trained nearly 3,000 current Invisalign doctors internationally, with roughly 50% in EMEA and 50% in APAC.

In EMEA, Q4 was a stalwart quarter, up 42.7% year-over-year, driven by record Invisalign volumes in everything country markets as well as stalwart growth in the teen segment, which was up 75.1% from the prior year, reflecting continued success of their Teen 360 program. For the complete year, EMEA was up 38.6%, led by Iberia, France, and the UK, as well as their key expansion markets, led by Central and Eastern Europe. During 2018, they went direct in Turkey, Israel, and Russia, adding to their expansion country markets.

For APAC, Q4 was down sequentially, as expected, due to seasonally slower age in the region; up 49.3% year-over-year, with record Invisalign volume in almost every country market, led by China, Japan, and ANZ. Q4 results reflect continued stalwart growth from teenage patients as well as adults, with GP dentists up 77.1% year-over-year. During Q4, they trained 1,530 current doctors in APAC, of which half were in China. They held several clinical education events across APAC designed to assuage enlarge doctors' assurance and adoption of Invisalign treatment, including how censorious the iTero scanner is to drill growth.

For the year, Invisalign volume from the international doctors increased 45%, led by growth from China and their core EMEA country markets. In total, international volumes represented 41% of worldwide Invisalign case shipments. Despite their record results, they are still very clearly underpenetrated in APAC overall and specifically in China. As the second largest market for Align, China represents gigantic growth potential and their talent to expand and drive penetration across the region relies on their talent to be closer to doctors and their patients, communicate in local language, and, as much as possible, operate like a local company.

Late in Q4, they began fabricating Invisalign aligners in their current manufacturing facility in Ziyang, China, their first aligner fabrication facility outside of Juarez, Mexico. There's a temporary facility that will be replaced by their own pile in 2020. Over the next year, they will continue to build their manufacturing capabilities in Ziyang and ramp up production to serve the rapidly growing Chinese market. However, it will capture a couple of quarters to fully transition aligner production from Juarez to Ziyang and they would await manufacturing overhead in Ziyang to be underutilized during this period.

Product and technology innovation continues to be a key growth driver across their regions. Over the past year, they launched several current Invisalign offerings for both comprehensive and non-comprehensive treatment to give doctors more tools and choices to handle a greater purview of cases, from adults to teenagers and now even kids as green as 7 years old. In mid-2018, they launched a current Invisalign evaporate product with a more user-friendly iTero digital chairside smack and greater flexibility to handle a wider purview of mild to temper cases, such as crowded or gapped teeth that require teeth straightening prior to restorative treatments.

We likewise began offering Invisalign First, designed specifically to address a broad purview of younger patients, malocclusions, including shorter clinical crowns, management of erupting dentition, and predictable dental arch expansion. We're pleased with the initial uptake and customer feedback. In 2018, they shipped nearly 5,000 Invisalign First cases to over 1,300 doctors, primarily in North America, EMEA, Australia, current Zealand, and Japan.

And in October, they received FDA approval for Invisalign with mandibular advancement feature in the U.S., which is the only limpid aligner product to prove to simultaneously wobble teeth and the mandible in green patients. In Q4, they began shipping mandibular advancement in the U.S. Late in the quarter, they were seeing initial uptake along with continued ramp globally. To date, over 17,000 teenagers fill used Invisalign treatment with mandibular advancement, led by China, Canada, France, and Spain.

Overall, for the teen market, in Q4, over 87,000 teenagers started treatment with Invisalign limpid aligners, an enlarge of 37.3% year-over-year, driven by continued stalwart adoption across everything major regions, driven by both the Americas and EMEA regions. For Q4, year-over-year Invisalign teen patient growth for North America orthos increased 23.7% and international doctors were up 63.7%. For the full-year, total teen cases worldwide grew 40.3% to a total of 333,000 teenagers, or 27.1% of their total volume.

Our consumer marketing efforts are designed to build the category and drive require for Invisalign treatment through a doctor's office. They invest over $100 million each year in consumer marketing and programs, including TV, digital, companionable media, PR, event marketing, and, more recently, their Patient Concierge and Invisalign smack program. Their goals are to execute the Invisalign brand a household designation worldwide and to motivate consumers to seek Invisalign treatment through a doctor's office.

In Q4, they continued to observe stalwart digital engagement with consumers and had nearly 4 million unique visitors on the invisalign.com sites for a total of 17 million over the year. Other key metrics present increased activity and engagement with the Invisalign brand and are included in their fourth quarter slides.

The repercussion of the digital technology on their world, and specifically in their industry, is challenging their customers to evolve just about every aspect of their practice, especially how they engage with consumers and rotate them into patients. What worked for doctors in the past from a marketing, conversion, and workflow perspective will not work today. Consumers await more and are demanding different types of digital driven experiences. Many doctors don't know where and how to start. The work they are doing with their integrated consumer marketing platform, Patient Concierge service, and Invisalign smack program has given us better insights and information that we're sharing with doctors to assuage them reshape their practices.

For example, the Invisalign smack program is designed to attain consumers in a retail environment where they shop, play, and dine and educate them on the benefits of Invisalign treatment and value of getting a better smile and connect them with an Invisalign doctor. One of the ways they finish this is through the Invisalign store, which is owned and operated by Align. Invisalign stores bring the brand directly to consumers in a contemporary, interactive, digital environment. Consumers can browse, question questions, learn about Invisalign treatment and technology and the benefits of straightening their teeth. Visitors are offered a complimentary iTero intraoral 3D scan and a visual simulation of what their smile might recognize like after Invisalign treatment. Interested consumers are connected with a local Invisalign doctor's office of their choice to argue potential treatment options.

By the suspension of 2018, they finished with 12 locations in the United States and these stores are helping us learn more than ever about reducing barriers to treatment for potential patients so that they are excited about getting a better smile with an Invisalign doctor. In addition to providing potential leads to participating Invisalign practices, we're likewise seeing a positive halo outcome in increased growth rates for everything the Invisalign practices in the surrounding region whether they participate in the store network or not. Over the past year, more than 55,000 consumers visited an Invisalign store and nearly 10,000 received a complimentary scan. While they are still early in the development of their Invisalign stores and the overarching Invisalign smack Program, we're excited about its potential and the positive repercussion they can fill on require creation for Invisalign practices by engaging directly with consumers.

The Invisalign smack program is just getting started and continues to evolve. In October, they announced that they were partnering with a few Invisalign doctors in selected U.S. cities to pilot current ways to attain consumers and connect them directly with doctors to start Invisalign treatment. These Invisalign smack locations are owned and operated by doctors under a special license from Align and are intended to assuage doctors integrate consumer-friendly design and consultation workflow into their practices and test current Invisalign smack branding and explore a consumer-focused approach to consultations and Invisalign treatment starts in a variety of settings, including in-office, retail, and mobile. We'll continue to share their learnings as they pickup more of these pilots up and running.

Finally, I want to spend a few minutes talking about digital technology and the transformation in their industry from an ancient analog process to an end-to-end digital workflow. Align is helping doctors on their digital journey, which starts with an iTero scanner and ends with stronger practices and better smiles for their patients. As a leader in digital orthodontics, they are best positioned to assuage Invisalign trained doctors find more efficient ways to drive digitization in their practices and support those practices and to assuage them better their productivity over time.

To that end, terminal year they launched Project Pino -- which they fill renamed Adapt: Align Digital and drill Transformation -- with several small orthodontic clinics across EMEA, APAC, and North America, with the objective to demonstrate that a fully digital drill can be productive, efficient, and profitable. The process involves minute analysis of the current drill data and workflows, performed by experts in continuous improvement and workflow.

While it is still early, the initial results from the accommodate study are incredibly promising. Based upon the study on drill development, we've approach to the conclusion that to profit fully from technology and to own the digital transformation of their practices, doctors need to organize their workflows and premises so that approximately 80% of their organization is built around this digital transformation with limpid aligners. This means that doctors who confide to digital transformation fill the potential to finish more, observe more patients, and expand their drill or capture more time off, whatever their goals. With Invisalign plus iTero together, they can assuage them observe the benefits they want from a fully end-to-end digital workflow.

For iTero scanner and services business, Q4 was a very stalwart quarter with better than expected revenues, which were up 13% sequentially and 54.8% year-over-year, driven by strength in everything regions and customer channels. Record Q4 volumes reflect continued commercialization of the iTero 2 component and the component Flex scanners, especially for restorative GP dentists in North America, the continued rollout of their major DSO partners, and increased sales internationally, including Italy, Japan, and China, where they began manufacturing the iTero component this past year.

For 2018, they had an outstanding year for iTero scanners with volumes up 77.2% year-over-year. Cumulatively, over 11.5 million orthodontic scans and 3.2 million restorative scans fill started with iTero scanners. employ of the iTero scanners for Invisalign case submission continues to grow and remains a positive leaven for Invisalign utilization.

For Q4, total Invisalign cases submitted with a digital scanner in the Americas increased 72.6% from 65.3% in Q4 terminal year. International scans increased 57.5%, up 41.4% in the same quarter terminal year. What's really exciting to observe is that, within the Americas, 88.7% of cases submitted by North American orthos were submitted digitally. And China went from 0% to 45.9% in one year. This means that within one year or two, nearly everything Invisalign cases will be submitted digitally, primarily through an iTero scanner. We're very excited about the continued progress we've made with the iTero trade overall and remain confident that it will continue to assuage drive their overall growth and assuage enlarge adoption of Invisalign treatment.

With that, I'll now rotate the convene over to John.

John F. Morici -- Chief monetary Officer

Thanks, Joe. Now, for their Q4 monetary results. Total revenue for the fourth quarter was $534 million, up 5.7% from the prior quarter and up 26.7% from the corresponding quarter a year ago. For the complete year, revenue of about $2 billion was up 33.5% year-over-year, reflecting a record 1.2 million Invisalign shipments and 31.9% year-over-year growth, with strength across everything regions and customer channels as well as record iTero scanners volume, which was up 77.2%.

For limpid aligners, Q4 revenue of $445.6 million was up 4.3% sequentially on higher than expected Invisalign ASPs and stalwart Invisalign volume from EMEA. Year-over-year limpid aligner revenue growth of 22.4% reflected stalwart Invisalign shipment across everything customer channels and geographies.

Q4 Invisalign ASPs were up sequentially by approximately $5.00 to $1,235.00, reflecting price increases and lower discounts, partially offset by higher growth on non-comprehensive cases, and includes $10.00 of unfavorable strange exchange. On a year-over-year basis, Q4 Invisalign ASPs were down approximately $70.00, reflecting promotional discounts, higher growth on non-comprehensive cases, and includes $25.00 of unfavorable strange exchange, partially offset by price increases.

Total Q4 Invisalign shipments of 333,800 cases were up 4.5% sequentially and up 30.9% year-over-year. For Americas orthodontists, Q4 Invisalign case volume was slightly lower than their Q4 outlook primarily due to longer cycle times in Latin America, and was down 2.9% sequentially and up 24.7% year-over-year. For Americas GP dentists, Invisalign case volume was up 3.2% sequentially and up 17.3% year-over-year. For international doctors, Invisalign case volume was up 12.2% sequentially and up 45.3% year-over-year.

Our scanner and services revenue for the fourth quarter was $88.4 million, up 13% sequentially, due to volume increases in Americas and EMEA. Year-over-year revenue was up 54.8%, primarily due to higher scanner units across regions.

Moving on to vulgar margin, fourth quarter overall vulgar margin was 71.7%, down 1.9 points sequentially and down 3.8 points year-over-year. limpid aligner vulgar margin for the fourth quarter was 74.1%, down 1.2 points sequentially, primarily due to a higher number of aligners per case, higher freight costs reflecting faster international growth, higher training costs due to more doctors trained in the quarter, and manufacturing spend driven by operational expansion in China, which was partially offset by slightly higher Invisalign ASPs. limpid aligner vulgar margin was down 3.5 points year-over-year, primarily due to higher number of aligners per case, lower ASPs, higher training costs and freight charges, and regional expansion of their manufacturing related activities in China and EMEA. Scanner vulgar margin for the fourth quarter was 59.9%, down 4 points sequentially and down 2.1 points year-over-year, primarily due to manufacturing and freight costs and lower ASPs.

Q4 operating expenses were $262.6 million, up sequentially 6.5% and up 26.1% year-over-year. The sequential enlarge in operating expenses primarily reflects their continued investment in sales and R&D activities, along with higher legal consulting expenses, partially offset by seasonality lower advertising spending. Year-over-year, the enlarge in operating expenses reflects higher spending commensurate with growth.

Our fourth quarter operating income was $120.5 million, down 3.8% sequentially and up 9.9% year-over-year. The sequential reduce in operating income is primarily attributed to lower vulgar margin and higher operating expenses, as mentioned earlier. On a year-over-year basis, the enlarge in operating income primarily reflects higher revenue offset by higher sales and marketing, R&D, legal consulting spending, and unfavorable strange exchange.

Our fourth quarter operating margin was 22.6%, down 2.2 points sequentially and down 3.4 points year-over-year. The sequential reduce in operating margin is primarily due to lower vulgar margin, as mentioned earlier. On a year-over-year basis, the reduce in operating margin is primarily due to lower vulgar margin, as described earlier, and about 0.5 points repercussion from unfavorable strange exchange.

With regards to fourth quarter tax provision, their tax rate was 8.5%, which includes approximately $1.9 million in excess tax benefits related to stock-based compensation.

Fourth quarter diluted earnings per share was $1.20, down $0.04 sequentially and up $1.07 compared to the prior year.

Moving on to the equipoise sheet, as of the fourth quarter, cash, cash equivalents, and marketable securities, including both short- and long-term investments, were $744.5 million, an enlarge of approximately $131.3 million from the prior quarter, which is primarily due to higher cash current from operations. Of their $744.5 million of cash, cash equivalents, and marketable securities, $432.5 million was held in the U.S. and $312 million was held by their international entities.

Q4 accounts receivable equipoise was $439 million, up approximately 4.5% sequentially. Their overall days sales outstanding was 74 days, down one day sequentially and up five days as of Q4 terminal year.

Cash current from operations for the fourth quarter was $241.3 million, up $79 million compared to the prior year. Free cash current for the quarter, defined as cash current from operations less capital expenditures, amounted to $187 million. Capital expenditures for the fourth quarter were $54.3 million, primarily related to their continued investment in increasing aligner capacity and facilities.

During Q4, they repurchased $50 million of stock against their stock buyback authorizations and fill $500 million still available for repurchase under the May 2018 repurchase program.

Before they wobble to the Q1 outlook, I would like to execute a few comments on their full-year 2018 results. In 2018, they shipped a record 1.2 million Invisalign cases, up 31.9%. This reflect 45% volume growth for their international doctors and 24.2% volume growth from their Americas doctors. Shipments of their iTero scanner were up 77.2% versus 2017. Total revenue was a record $2 billion, up 33.5% year-over-year, with Invisalign revenues of $1.7 billion. Full-year operating income of $466.7 million, up 31.9% versus 2017, and operating margin at 23.7%. Free cash current was $331.4 million. For the year, they repurchased 1.1 million shares of Align stock for $300 million. 2018 diluted earnings per share was $4.92.

With that, let's rotate to their Q1 outlook and the factors that inform their view, starting with the require outlook. For international, they await Q1 to be up sequentially, as the EMEA market maintains momentum from Q4 and APAC is seasonally flat sequentially as some markets solemnize the Lunar current Year holiday. For Americas, they await Q1 to likewise enlarge sequentially, with stalwart growth from North America orthos and a slight enlarge in North America GPs. They await Latin America to be down sequentially given this is their summer holiday season. They await their iTero trade to be down slightly from a record Q4, consistent with seasonal trends in capital tackle market. And they continue to await minimal volume from smile Direct Club.

With this as a backdrop, they await the first quarter to shape up as follows. Invisalign case volume is expected to be in the purview of 340,000 to 345,000 cases, up approximately 25% to 27% year-over-year. They await Q1 revenues to be in the purview of $525 million to $535 million, reflecting increased volume and flat ASPs versus Q4 2018. They await Q1 vulgar margin to be in the purview of 70.3% to 71%, reflecting their higher start-up costs in China and increased doctor training expenses. They await Q1 operating expenses to be in the purview of $290 million to $294 million, which reflects their salesforce expansion and increased legal expenses. Q1 operating margin should be in the purview of 15.1% to 16.1%.

Our effectual tax rate should be approximately 16%, which is higher than 2018 due to non-deductible officer stock compensation based on recent IRS guidance and a lower stock price. They await an approximately $3 million to $4 million equity loss related to their share of smile Direct Club's net losses and diluted shares outstanding should be approximately 80.9 million, exclusive of any share repurchases. Taken together, they await their Q1 diluted earnings per share to be in the purview of $0.78 to $0.84. In addition, as they continue their operational expansion efforts, they await CapEx for Q1 to be approximately $60 million to $65 million and they await depreciation and amortization to be $19 million to $20 million.

Now, let me rotate to their view for the full-year 2019, notwithstanding the repercussion of strange exchange rates. They await total revenue growth for the company, Invisalign, and iTero to be in the middle purview of their long-term operating model of 20% to 30%. They anticipate Invisalign ASPs to be flat from Q4 2018, reflecting continued growth from international regions, increased share of the teen segment, and uptake of non-comprehensive products. They anticipate Invisalign volume to be in the middle of the purview of their long-term model target of 20% to 30%.

We anticipate vulgar margin and operating margin to better over the course of the year. They anticipate vulgar margin to approach their long-term model target of 73% to 78% by Q4. They will continue to fuel growth globally and await to invest in international and operational expansion, as well as sales and marketing initiatives, including nearly 100 current sales reps in Americas hired at the suspension of Q4 and additional GP sales reps in EMEA rise in Q1. These investments likewise comprise continued litigation expenses to protect their intellectual property and extend their competitive advantage.

Given their continued growth and expansion internationally, during the year, they intend to reorganize their corporate structure and intercompany relationships to more closely align with the international nature of their trade activities. The proposed corporate structure may likewise allow us to obtain monetary and operational efficiencies after they are implemented. As a result, they will incur expenses in the near term and await to realize the related benefits in subsequent years. They await their operating margin for the second half to be in the long-term model of 25% to 30%. For the complete year, they anticipate operating margin to be below their long-term target, as it includes approximately 1.5 points to 2 points repercussion from increased legal fees and the planned corporate structure reorganization.

We await the equity loss for their investment in smile Direct Club to be $3 million to $4 million per quarter. They await their tax rate for 2019 to be approximately 24%, which includes about $8 million of excess tax benefits. 2019 tax rate is higher than 2018 primarily due to a release of unrecognized tax benefits that will not repeat. They await their earnings power in the second half of the year to be stronger than the first half, with second half operating results to account for somewhere in the purview of 50% to 55% of their full-year results. They await capital expenditures for 2019 to be in the purview of $250 million to $260 million.

With that, I'll rotate it back over to Joe for final comments. Joe?

Joseph M. Hogan -- President and Chief Executive Officer

Thanks, John, and thanks to those who joined their convene today. Overall, 2018 was a majestic year for Align and I'm very pleased with the stalwart performance for Invisalign and iTero across everything key regions, customers, channels, and products. This year, not only did they celebrate their 21st year in business, they likewise achieved several major milestones, including their sixth millionth Invisalign patient and $2 billion in revenue for the first time. It took nearly 20 years to attain their first billion dollars in sales and only two years to attain their second billion.

We likewise delivered on their strategic growth drivers, with current product and technology innovation, expansion of their manufacturing and treatment planning operations, and raising awareness of Invisalign treatment with consumers and engaging with them in more innovative ways than ever before.

As I step back and recognize ahead to 2019 and beyond, I want to reinforce the consequence of the investments we're making to drive growth globally. The underlying opportunity for doctors and their patients is expanding based on digital technology that Align has spent over 21 years developing. And while they fill a huge amount of accumulated expertise and information in digital technology in orthodontics, they fill to ensure that they fill the capabilities to further expand and regionalize their operations, extend their competitive lead, and protect their trade from companies willing to capture shortcuts with respect to intellectual property. It is incumbent upon us to drive the transition to a fully digital workflow and continue to deliver current products and services that not only profit Invisalign doctors but their patients and consumers alike.

Following their ortho climax in November, I met with hundreds of Invisalign doctors and their staff. I had the opportunity to travel to regional kickoff meetings and connect with Align team members at every level of their organization to hear their minute plans for the upcoming year. While I spent more of my time at the Americas kickoff because of my interim role as Americas leader, I can suppose unequivocally that across the company the excitement and level of engagement surrounding their trade and market opportunity was palpable.

Overall, the require profile globally is solid and nothing they observe in the environment suggests otherwise. We're running the plays they know and are confident they can bring greater efficiencies, economies of scale, and know that adding sales training to pickup closer to customers in local markets creates sustainable competitive advantage.

Finally, as most of you know, one of the key orthodontic journals in North America is The Journal of Clinical Orthodontics and I often flip through it and question why there aren't more limpid aligners profiled. This week, I was caught off guard when I opened the December issues and create it dedicated entirely to limpid aligner therapy. Bob Keim is the editor of the JCO and has been to many of their Invisalign summits. In meetings with him and reading his editorials, I knew he supported Invisalign treatment and limpid aligners, in general, but it was never limpid to me the extent he believed in limpid aligner technology as we've seen in the most recent issue of the JCO, especially the editor's column, "The suspension of Braces." If you haven't had a chance to read the JCO, you should. Bob could not capture a stronger position for limpid aligners. He acknowledges that he may capture some flak for being so bold but I believe his stalwart endorsement is a major breakthrough for Align and digital orthodontics.

With that, I want to thank you again for joining their call. I recognize forward to updating you on their progress as the year unfolds. We'll observe many of you at the Chicago mid-winter meeting next month, as well as industry and monetary conferences throughout the year. Now I'll rotate the convene over to the operator for questions. Operator?

Questions and Answers:

Operator

Thank you. They will now be conducting a question-and-answer session. If you would like to question a question, gladden press "*1" on your telephone keypad. A confirmation tone will testify your line is in the question queue. You can press "*2" if you would like to remove your question from the queue. For participants using speaker equipment, it may be necessary to pick up your handset before pressing "*". One moment, please, while they poll for questions.

And thank you. Their first question comes from the line of Robert Jones with Goldman Sachs. gladden proceed.

Robert Jones -- Goldman Sachs -- Analyst

Great. Thanks for the questions. I guess just start on ASPs. Joe, could you maybe talk through the progression of ASPs that you saw over the quarter? On a worldwide basis, it certainly seems like you guys were able to stabilize ASPs in 4Q relative to 3Q and looking at the implied guidance from 1Q, it seems like that's expected to continue. And in the complete year, you're calling for that to be the benevolent of level they should recognize for. So, I guess just how did they progress throughout 4Q? And then just related to that, what are the major pushes and pulls as you mediate about ASPs over the course of '19?

Joseph M. Hogan -- President and Chief Executive Officer

Bob, that's a sizable question but let's execute it simple. They had an issue in the third quarter in the Americas with their odds program that I mediate kicked off this ASP concern. As they said we'd do, they retracted that $300.00 that they offered on teens and likewise adults at that point in time. After that, basically their ASPs are what they normally are in the sense of mixes and matches across a spectrum of EMEA and different places. So, I mean, that's the total. They fill an exchange hit this quarter likewise but, again, I mediate they prepared you for that terminal quarter. So, overall, the only change is they didn't fill an odds issue in the fourth quarter.

Robert Jones -- Goldman Sachs -- Analyst

Yeah, I guess just to result on that, Joe, I mediate the question really is, as you mediate about '19, obviously those programs evaporate away. I guess the expectation looks like here in the slides that you're still thinking it's going to be flat to the 4Q level. So, just trying to understand a petite bit better what could wobble the ASPs up over the course of the year as they mediate about some of the things that hopefully would not reoccur in '19 that happened in '18.

Joseph M. Hogan -- President and Chief Executive Officer

Yeah, John will jump in on this.

John F. Morici -- Chief monetary Officer

Yeah. Hi, Bob, this is John. So, the couple positive fuse that they talk a lot about is the international growth -- they would continue to observe stalwart growth internationally. Mandibular advancement in the U.S. contributes overall to their teen growth, which are comprehensive cases and those help. And they are likewise seeing growth on the non-comprehensive side. So, they mediate those three -- they observe some equipoise and that's what they would await for 2019.

Robert Jones -- Goldman Sachs -- Analyst

Great. And then I guess just a follow-up for me, John, while I fill you. If you mediate about the margin outlook for the year, it looks like you guys are calling for the growth in operating margins to pickup into the long-term ranges in the back half. Just at a tall level, I guess, how much visibility and control finish you guys fill over that trajectory into the back half of '19 around the margins?

John F. Morici -- Chief monetary Officer

Yeah. It really starts with some of the manufacturing efficiencies that they await to pickup as they start to ramp up in China and continue to ramp up with their treatment planning. We'll observe that continue to ramp as they wobble through the year. They fill other products and programs that will likewise assuage us from a fuse standpoint as well. So, they feel really kindly about how they view the year and the expectation of margin improvement throughout the year.

Robert Jones -- Goldman Sachs -- Analyst

That's helpful. Thanks.

Joseph M. Hogan -- President and Chief Executive Officer

All right, Bob. Thanks.

Operator

Thank you. Their next question comes from the line of Elizabeth Anderson with Evercore ISI. gladden proceed.

Elizabeth Anderson -- Evercore ISI -- Analyst

Hi. kindly afternoon. I was wondering if you could talk to us a petite bit more about the reorganization expenses. Are you sort of thinking of those on an ongoing basis or more one-time? I guess my question stems, in part, because I was wondering if you were thinking about potentially backing those out of your 2019 results. Thanks.

John F. Morici -- Chief monetary Officer

Hi, Elizabeth. This is John. This is one-time. I mean, as the company expands and grows internationally, it's looking at some of the efficiencies they can gain through that change. And they report numbers on a GAAP basis. We'll continue to finish so but we'll give you highlights as the year goes on as an update.

Elizabeth Anderson -- Evercore ISI -- Analyst

Okay. That's helpful. And I guess, also, can you just talk a petite bit more about the sales investments that you guys are making into the Americas in terms of any particular details you could provide on that? That would be helpful. Thanks.

Joseph M. Hogan -- President and Chief Executive Officer

Yeah, Elizabeth. It's Joe. Look, Americas, we're still really underpenetrated in the marketplace, particularly on the GP segment. And so they decided they would add 100 salespeople. They feel really kindly about that investment giving us kindly short-term returns. We've done this before, almost in every cycle since I've been here. It's a play they know how to Run and they know the consequence of it overall. So, don't recognize at it as an anomaly. It's just a continuation of pile out their salesforce and taking odds of some of the require out there.

Elizabeth, I'll likewise bid you, it's a high-touch thing. You fill to paw doctors in this trade to drive sales. And it just doesn't befall by itself. There's a constant paw to it so, I mean, we're really alert of that. Often their treatment is much different than what these doctors fill done before. And their salespeople, they train them well clinically but likewise from a trade standpoint so that they can talk about, clinically, how to employ the product line but also, from a trade standpoint, how you integrate it into the practice. So, adding salespeople is really important.

Elizabeth Anderson -- Evercore ISI -- Analyst

Thanks. That's really helpful.

Shirley Stacy -- Vice President, Corporate Communications and Investor Relations

Next question.

Operator

Thank you. Their next question comes from the line of Jonathan block with Stifel. gladden proceed.

Jonathan block -- Stifel, Nicolaus & Co. -- Analyst

Great. Thanks, guys. kindly afternoon. I mediate the paranoia is gonna sort of wobble from ASPs to volumes and margins tomorrow. So, maybe on the margins side, John, for '19, you mentioned expectations to be below your long-term op margin goal of 25% to 30%. Specifically, you called out 150 to 200 bps from increased legal fees and the reorg. So, a couple of questions there.

Is that reorg everything specific to '19? And then if they were to normalize for the 150 to 200 bps, would your '19 op margin approach the lower company of your long-term 25% to 30% goal? And then I've just got a quicker follow-up.

John F. Morici -- Chief monetary Officer

Yeah. That's the birthright course to recognize at it, John. So, this is 2019 expenses and they mediate they would fill been in the long-term purview that they fill of 25% to 30% if they didn't fill these expenses.

Jonathan block -- Stifel, Nicolaus & Co. -- Analyst

Okay. Long question, short answer. I'll capture it. And then maybe, Joe, for you, on the volumes. Just any more color? I mean, any thoughts on the North American ortho weakness? I finish fill a difficult time believing that everything of the weakness was Latin America, just looking at the size of that business. But anything more in North American ortho weakness? Is this a suspension before mandibular and Invisalign First capture greater hold in 2019? And maybe, if you don't mind, any thoughts on what MAV and First could contribute to North America this year? Thanks, guys.

Joseph M. Hogan -- President and Chief Executive Officer

John, look, the Americas growth this year -- I know they had the blip in the third quarter overall -- but 2018 is a kindly year for us. You recognize at the terminal six years, this is actually the second highest growth profile we've had. Americas grows about 17% on an incurious over those six years. The orthos grew. This is the second, from a percentage standpoint, best year we've had from an ortho standpoint. What happened between the third and fourth quarter, and I mentioned on my opening, was the uptake that they had with that odds program in the third quarter and that wasn't repeated in the fourth quarter and they mediate they fill this quarter-over-quarter benevolent of discrepancy. GPs are at an all-time tall from a growth standpoint overall. And then, obviously, from a Brazil standpoint, too, it's starting to become material in the sense of the size of that trade and we're looking for kindly contributions this year.

So, John, I don't know if I'm answering your question but I'd suppose if you recognize at the volume overall, you observe how stalwart EMEA has been. The expansion of EMEA into areas like Turkey and Russia and in the Middle East has been necessary to us. But likewise France is growing well, Spain's been strong, Italy came back, they saw it. We've had majestic success with evaporate with the GPs out of the UK but likewise in Germany too. So, they really feel majestic about that region. And then APAC. Again, they observe strength. They observe strength in China, they observe strength in APAC overall. Japan's growth has been phenomenal. And then bleed that in with their iTero growth, too, that you've seen across the spectrum. Overall, they feel kindly about volume.

Jonathan block -- Stifel, Nicolaus & Co. -- Analyst

Okay. just enough. Thanks for your time, guys.

Operator

Thank you. Their next question comes from the line of Brandon Couillard with Jefferies. gladden proceed.

Brandon Couillard -- Jefferies -- Analyst

Thanks. kindly afternoon. Just a couple of housekeeping items, John, in terms of the fourth quarter. Could you quantify the repercussion in Latin America from the longer cycle times? And you await that to normalize in the first quarter? And then in terms of the fourth quarter OpEx, it looks like it was about $12 million above their guidance, which is very atypical and unusual. Can you point us to the areas of spend that were perhaps accelerated or brought you in above your plan?

John F. Morici -- Chief monetary Officer

Yeah. So, for the fourth quarter in Latin America, it's a growing business, as Joe said. It's a couple thousand cases that were benevolent of in transition birthright at the suspension of the fourth quarter. And then as far as spend, were you specifically talking about spend in fourth quarter or compared to the sheperd in the first quarter?

Brandon Couillard -- Jefferies -- Analyst

Yeah. The fourth quarter OpEx relative to your guidance.

John F. Morici -- Chief monetary Officer

Yeah, they saw added litigation expenses as we've been going as a allotment of their process that they fill on the legal side. There's some added costs that we're showing there. And as Joe said, they added some salespeople and some of those hires and those expenses came into fourth quarter but they wanted people on the ground and ready to be able to sell and give us volume as soon as feasible into 2019. So, some of those costs hit there as well.

Brandon Couillard -- Jefferies -- Analyst

Thanks. And then coming back to ASPs for 2019, it would look to imply that worldwide ASPs for the year would be down about 3% year-over-year. I understand currency is probably half of that. fuse is another dynamic. But would it be your expectation that promotional activity would be sort of consistent year-over-year or is there some cushion built in perhaps for more promo activity in '19 relative to terminal year?

John F. Morici -- Chief monetary Officer

I would suppose there's nothing specifically that we're looking at, additional promotions or others. They recognize at the trade as they fill various products and current products that approach out, changes that they make. They recognize at promotions to be able to drive volume and drive uptake across the regions. So, they vary by region. But nothing out of the ordinary and they were pleased to observe where ASPs finish and fill a kindly expectation, given the positive growth internationally, the positive growth that they observe on teens, and we're seeing stalwart non-comprehensive growth. everything that taken into accounts keeps us flat for ASPs.

Brandon Couillard -- Jefferies -- Analyst

Very good. Thank you.

Shirley Stacy -- Vice President, Corporate Communications and Investor Relations

Thanks, Brandon. Next question, please.

Operator

Thank you. Their next question comes from the line of Steve Beuchaw with Morgan Stanley. gladden proceed.

Steve Beuchaw -- Morgan Stanley -- Analyst

Hi. kindly afternoon and thanks for the time here. I wanted to focus on how you thought about incorporating any potential contribution from the salesforce additions in the outlook for 2019. If I mediate back to past years where there fill been substantial adds to the salesforce, something like six months after those feet hit the street, they saw a benefit. So, in 2019, are you modeling in any profit from these rep adds that you made already? If so, can you give us a sense for how sizable those might be? Because I'm just curious, as they mediate about the outlook for the year, let's convene it 25% on volumes, 25% to 27% in the first quarter, it just doesn't recognize like there's an anticipation of acceleration or profit from those hires.

John F. Morici -- Chief monetary Officer

Yeah, Steve, this is John. Six months to nine months is benevolent of the purview you would await to really start seeing those salespeople that you add, once they're fully trained and fill their territories and can benevolent of hit. So, they should observe an acceleration in the second half, given the adds that they have. And as they see, they factored into their sheperd as much as they can observe now based on those adds.

Steve Beuchaw -- Morgan Stanley -- Analyst

Okay. And then I would accord with the comment that was made earlier about where the paranoia is going to shift. So, I just wanted, in allotment in response to the many emails I've gotten here in the terminal 45 minutes or so, give you a chance to just comment on your thinking on competition. Is there any token of competition being pertinent in the domain that you can pick out at this point or still of the view that it's just not material and not something that people ought to be thinking about?

Joseph M. Hogan -- President and Chief Executive Officer

Hey, Steve. It's Joe. Obviously, we've seen Ormco down in ANZ and I mediate they saw a recent announcement that they are gonna benevolent of pace themselves as they evaporate through 2019. I mediate you're seeing the same thing out of 3M too. So, honestly, Steve, they know you guys finish surveys. They read your surveys. They finish their own and whatever. They know some of the docs out there are trying these product lines and they fill access to some of the software that's going on out there and the product lines that they're representing or whatever. I don't diminish it but as far as 2019 goes, we're not thinking about any major competitive issues that we're gonna face in any of their key areas or key geographies birthright now. They mediate this will capture some time for them to ramp.

We've talked about this before. This trade is not easy. You fill to be able to hit on a lot of cylinders. You've got to fill a kindly salesforce that touches the customers and can execute that doctor feel really stalwart about the product line. Secondly, you fill to fill really kindly treatment planning and consistent treatment planning that can deliver. And, third, you've got to fill an operation organization that can deliver these things in sequence and on time and at a tall quality. And putting those things together is difficult. And so 2019, we're not factoring in a huge amount of what they mediate is competitive pressure.

Steve Beuchaw -- Morgan Stanley -- Analyst

Okay. Got it. Thanks a bunch.

Joseph M. Hogan -- President and Chief Executive Officer

All right, Steve. observe you, man.

Operator

Thank you. Their next question comes from the line of Erin Wright with Credit Suisse. gladden proceed.

Erin Wright -- Credit Suisse -- Analyst

Great. Thanks. A couple of international ones here. I guess, can you converse to the dynamics, in terms of fundamental require trends in China given broader macro dynamics, and could you likewise converse to the competitive landscape and how that's evolving there? And then likewise on Brazil, just as you build out that market, any sort of surprises there that you're seeing in the broader traction in Brazil? Thanks.

Joseph M. Hogan -- President and Chief Executive Officer

Yeah. Erin, this is Joe. From a China standpoint, their require there has been great. I think, as I talked about in my opening, it's a really underpenetrated marketplace. And there's a lot of require for their product line. And so their manufacturing investments we're making there, their treatment planning, everything those things to execute us a local company they mediate will allow us to really penetrate that market at a higher rate. So, look, we're not numb to the international scene birthright now where people are concerned about China demand. They don't fill anything to report birthright now that would suppose that they fill a diminishing or a paranoia over China require as they evaporate into 2019.

As far as competition over there, Erin, Angel Align is the most credible competitor that they fill there. I would suppose that Angel has really focused on benevolent of Tier 3 cities and areas of Chinas, where we've really focused on, in the first five years or so of their being in China, Tier 1 or 2 cities and we've moved into Tier 3. They don't feel that Angel is throttling their growth there at all. They are a expeditiously follower. They observe them in different areas that approach after us but there's not a total lot of head-to-head competition they feel birthright now.

And I mediate that reflects not a total lot about Angel being either kindly or bad, it just reflects the size of this marketplace and the investments you fill to execute in a salesforce, how you really fill to service that marketplace. There's a lot of work that you fill to do. The channels just don't exist birthright now in a sense. And you fill to build those channels and really execute them viable. So, birthright now, they regard them a competitor and their largest competitor, I'd say, in the world, in the sense of the number of limpid aligners that they supply. They don't recognize at them birthright now as slowing us down in China.

The Brazil surprise, I'd suppose the surprise for everything of us in Brazil is the incredible uptake of their product line there. You saw the 1,300 doctors that we've trained there recently. They're so excited about the product line. They talk about Spain often, in the sense of the uptake of their product in Spain and the growth there. They observe the same benevolent of enthusiasm and the same benevolent of what I would convene Latin enthusiasm for what their product can finish and really bring to that area. So, they recognize to execute major investments there and increasing their salesforce and their presence in the Brazilian area. And they really feel kindly about Brazil from a standpoint of future growth of their product line there.

Erin Wright -- Credit Suisse -- Analyst

Okay. Great. Thanks. And a broader question on promotional activity. I'm just snoopy what other promotional activity could you implement that isn't necessarily price driven, whether it be co-marketing arrangements or other types of incentives. Is this something that is in your game design for 2019 or something that you're planning? Thanks.

Joseph M. Hogan -- President and Chief Executive Officer

Erin, there's no want of creativity in their commercial forces, as promotions go. There's a lot of adult supervision that they fill to supply as they finish those things. And when you recognize at their accommodate program as a kindly one, that's a program where we're trying to capture doctors to 80% Invisalign and really demonstrate, as I mentioned in my opening, when you pickup to a digital drill and you pickup to 80% -- first of all, no one goes back. No one goes back to wires and brackets. You really set a precedent and that you fill control over your practice. You don't fill 30% of your cases resulting in emergencies. Doctors aren't spending 45 minutes a day with patients. But you fill to pickup to 80% to execute that work. We'll continue to attach money into that. That's not like a promotional program that they would present at a lower price. That's just a program they work with docs who really want to pickup there.

There's always promotional programs that they do. They present aligners to staff at orthos that are starting up with us. Also, with GPs or whatever, so that they can understand the product and fill that smack and be able to communicate that well to patients as they approach into the practice. Those are ongoing promotions that they finish in everything three geographies too. They finish fill seasonal promotions at times in different countries or different areas but I'd suppose that they fill -- this is outside of the third quarter issue, obviously, they reported on benevolent of ad nauseam over the terminal six months. They fill a kindly wield birthright now on what promotions we'll present throughout the year.

Shirley Stacy -- Vice President, Corporate Communications and Investor Relations

Thanks, Erin. Next question, please.

Operator

Our next question comes from the line of Ravi Misra with Berenberg Capital Markets. gladden proceed.

Ravi Misra -- Berenberg Capital Markets -- Analyst

Hi. Thank you for taking the questions. So, I wanted to pickup into benevolent of the vulgar margin outlook and the commentary that you were providing. And can you assuage us understand maybe what the pushes and takes are between that 1Q guidance and benevolent of the 4Q guidance ramp? And especially in terms of what's that fixed overhead that's trapped there? benevolent of in the ballpark, does that approach somewhere around $10 million to $15 million a quarter birthright now that's annualizing through your COGS on that that's gonna tumble off once the China sales ramp?

John F. Morici -- Chief monetary Officer

Yeah. Hi, Ravi, it's John. It's not that tall but when they mediate of their operation that we've had to date, really, it's treatment planning in Costa Rica and it's been manufacturing in Mexico. They are now, as we've been expanding their treatment planning and now expanding the China manufacturing, they want volume. They want to be able to propel volume through those centers and pickup as much productivity as possible. So, as they observe some of the margin repercussion in the fourth quarter, that continues a bit into the fourth quarter, but as that volume comes through and as you don't fill to add as much overhead, you observe more and more productivity to be able to approach through those, whether it's treatment planning or the China manufacturing. And so they await to observe this benevolent of quarter-over-quarter improvement through 2019 as they pickup more and more productive at these facilities.

Ravi Misra -- Berenberg Capital Markets -- Analyst

So, it sounds like that's really gonna be led by a step-up in the limpid aligner vulgar margin versus the scanners?

John F. Morici -- Chief monetary Officer

Yes, definitely. When you recognize at benevolent of where we're seeing that volume leverage as they expand out globally, it will be on the limpid aligners side and they should observe that progress through the year.

Ravi Misra -- Berenberg Capital Markets -- Analyst

Great. And then maybe just two more questions. Just one on the orthodontics and then another benevolent of just on the consultations through the Invisalign brand experience. So, just on the orthodontic step-down, I'm curious. That's the first time in, gosh, I mediate about 12-14 quarters I've seen that number step down. Any benevolent of repercussion -- I know you're saw that the repercussion from Ormco and 3M was benevolent of limited, but how about some of the other direct-to-consumer manufacturers there? Is that playing into that at all? And in the sense that that suspension user volume might actually be going down?

And then, second, you talk about the 85,000 people that fill visited the store and gotten a consult. What's the conversion rate on that? Those getting scans to actually becoming consumers of your product? Thanks.

Joseph M. Hogan -- President and Chief Executive Officer

Hi, Ravi. Joe again. From a standpoint of Americas, an orthodontic standpoint, again I'll bid you, they had their second best year in history from the standpoint of overall orthodontic growth. When you talk about SDC, my sentiment on SDC is they don't really capture orthodontic cases. Remember, the intimate orthodontist in the United States is 75% to 80% teen. You won't observe many teens being done by SDC. And so those cases would primarily approach out of GPs. Adults, benevolent of simple cases that are going on. As I mentioned, they had their highest GP sales rate ever in North American in 2018. So, on neither of those dimensions finish I mediate that they are experiencing competition that's throttling the trade in some course or that will impress us in 2019.

As far as the Invisalign stores and the scan ratios, everything those things, we're still working through these 12. They haven't released that information from an overall standpoint yet. And at some point in time, when they mediate we're ready and they really fill that ironed out. And I suppose that, Ravi, not that we're hiding anything. It's just they fill create that when you recognize at CCAs, what they would convene a "clear order" in this business, this can capture anywhere from 4-6 months to seven months to really iron itself out. They observe patients evaporate in and pickup scanned and then there's a huge halo outcome because they finish this local advertising that benefits not just the doctors in the program but also, in a broader sense, any doctor that's within that 10 mile or 15 mile range. So, when we're ready to report this, we'll report it in a broad sense of that halo effect, the total -- what you talked about -- the conversion rate, and likewise what that means from a timing standpoint. Okay?

Ravi Misra -- Berenberg Capital Markets -- Analyst

Great. Thank you.

Shirley Stacy -- Vice President, Corporate Communications and Investor Relations

Thanks, Ravi. Next question, please.

Operator

Thank you. Their next question comes from the line of John Kreger with William Blair. gladden proceed.

John Kreger -- William Blair & Co. -- Analyst

Thanks. Joe, a few times on the convene I mediate you talked about your view that it's sort of censorious to pickup your customers to really execute the digital conversion of their practices. Can you just talk a bit more about what that really means? And is that an expense on your part? Obviously, it's got some positive implications for volumes if and when it happens but what are the sort of practical implications of getting an ortho drill to execute that transition? Thanks.

Joseph M. Hogan -- President and Chief Executive Officer

Hey, John. That's a kindly question. There's three key parameters, right? First of all, there's extended payment terms that you fill to deal with because when you evaporate with a limpid aligner product versus wires and brackets, their cost overall are about 4x, from a variable cost standpoint, of what you'd fill with wires and brackets. So, you just fill to pickup ready for that cash play and try, in some way, to extend them that benevolent of payments.

Secondly, you fill to recognize at their workflows because when you really evaporate to a complete digital practice, it changes completely really. They create out in their accommodate program that you need fewer chairs but you need more consultation rooms to attach people in to present them simulations, to talk them through what it would be. With no emergency cases, it completely redefines the sense of how a day goes in a doctor's office. It's not 30% of the time are people scrambling around trying to find someone that can fix something that occurred with the wires and brackets in some way.

And then, third, there's a require component. You're gonna fill to drive more require within that practice, which Invisalign does. And so, obviously, with $100 million spend that they finish a year and attracting patients and stirring them into doctors, how they pipe those patients into doctors, how they prepare themselves for both teens and adults to finish that. So, it's on those three dimensions.

And, John, specifically on the accommodate program, we're just going through that program birthright now and how we'll present that to customers and what it will cost to actually finish that, to capture customers to that point. And after we've done probably 5-8 of these and fill them complete, we'll fill a better anecdote and a more complete story, in the sense of here's how we'll finish it, what those costs will be. But don't recognize at those as being overly broad. Remember, they fill I Pro today, which they basically employ to capture customers through clinical benevolent of episodes. So, they fill their Concierge service that grabs patients to wobble them through doctors too. So, the sizable components of operations that you need to work around the Adapt, they fill those in place, they just fill to modify them more for this 80% digital treatment plan.

John Kreger -- William Blair & Co. -- Analyst

Very helpful. Thanks. One quick one. John, as you mediate about the '19 outlook that you described for us, what sort of number of stores does that envision by year end?

John F. Morici -- Chief monetary Officer

We fill 12, as they noted, now. It's really not a material change from that. We're evaluating best locations, what makes sense for us, but they really want to drive productivity and conversion at the stores they fill before they evaporate on a larger scale.

John Kreger -- William Blair & Co. -- Analyst

Okay. So, they shouldn't await that to be materially different by December of '19?

John F. Morici -- Chief monetary Officer

That's correct.

John Kreger -- William Blair & Co. -- Analyst

Okay. Thank you.

Shirley Stacy -- Vice President, Corporate Communications and Investor Relations

Thanks, John. Next question?

Operator

Thank you. Their next question comes from the line of Steven Valiquette with Barclays. gladden proceed.

Steven Valiquette -- Barclays Capital -- Analyst

Thanks. kindly afternoon, everybody. So, I guess just given the ramp in investment in 2019, with likely some slower EPS growth, it benevolent of feels like 2019 is maybe Somewhat similar to what Align went through back in 2015, where that was, let's convene it, Somewhat of a throwaway year for earnings growth because of massive spending. But then the company came out of that and really had three stalwart years of growth in 2016 through 2018. I know it's a different management team back in 2015 but should they draw really any sort of parallels for 2019, where maybe you're just setting yourself up for another stalwart earnings growth cycle in the next couple of years beyond 2019 with the investments that you're making this year? Thanks.

Joseph M. Hogan -- President and Chief Executive Officer

Hey, Steve, it's Joe. First of all, I feel they play offense in this business. So, even though they talk about restructuring or if they talk about adding salespeople, they talk about defending their IP, everything of those things are, to me, setting a foundation for future growth in the business. When you step back and you recognize at this business, we're incredibly underpenetrated based on consumer preference for limpid aligners to wobble teeth and likewise the size of the market that digital opens up even beyond the 12 million orthodontic case starts that they talk about globally.

So, gladden don't convene 2019 a throwaway year. Hopefully, the earnings and the growth that we're projecting here are substantial. And they haven't even mentioned the law of large number on you guys over the terminal three years, right? Because they continue to build these employ percentages over the top of incredibly larger numbers than what they had previously. So, I'd recognize at it as these are aggressive investments in a green trade to lay a foundation to allow us to be better in the future. And they fill to capture these.

Steven Valiquette -- Barclays Capital -- Analyst

I guess the only quick follow-up to that would just be how necessary is consistent EPS growth at a line at this stage of the corporate lifecycle? Or is this still mainly about driving top line growth for everything the things that you just mentioned?

John F. Morici -- Chief monetary Officer

Hey, Steve, this is John. It's both. I mean, they want to drive top line. They want to be able to grow this business. As Joe mentioned, we're vastly underpenetrated and they fill products and technology to be able to enlarge that market. But at the same time, they want to be able to grow profitably and as they layer on some of these investments, they await -- whether it's China or it's salesforce addition or others that we're adding in -- over time, we'll be able to observe those benefits. And that over time, as they laid out, is over 2019, they should observe that sequential improvement quarter-over-quarter as those investments start to pay off as they wobble forward. But they want to execute positive that we're returning the most back to their shareholders and that comes from revenue growth and the volume that they drive, as well as doing this from a profitability standpoint and we're very alert of the long-term growth model and they stick with that.

Steven Valiquette -- Barclays Capital -- Analyst

Okay. Got it. Okay. Thanks.

Shirley Stacy -- Vice President, Corporate Communications and Investor Relations

Thanks, Steve. Operator, we'll capture one more question, please.

Operator

Thank you. Their next question will approach from the line of Richard Newitter with SPD Leerink. gladden proceed.

Richard Newitter -- Leerink Partners -- Analyst

Hi, thanks for taking the question. Hi. Joe, I was just wondering, I know it's still really, really early days in China and the opportunity is gigantic and clearly your growth rates in that region haven't really shown any slowdown, but can you just talk a petite bit about what -- we've seen some headlines and some other companies talking about the macro slowdown in China in the consumer discretionary realm -- can you give us your thoughts for the course you observe things? Clearly, you're investing so I would imagine there's nothing that would hint there's any slowing growth. But what are you seeing benevolent of at the ground level in terms of the macro?

Joseph M. Hogan -- President and Chief Executive Officer

Like I mentioned before, Richard, the growth that they saw throughout 2018 was really stalwart in China. I mean, obviously, we're making these investments in China as a commitment. They're their second largest country in the world birthright now. The underpenetration and the opportunity there is huge. Look, I mean, we're up with global events. They observe the issues going on with China and the United States and hopefully they'll approach to a trade deal sooner or later. I recognize at that investment that they talked about of manufacturing there as stirring closer and having a Chinese trade and being able to operate in that country with a lot of fluidity. But it likewise makes me feel kindly that they fill a kindly insurance policy, in the sense of the trade dynamics between the two countries too.

So, birthright now, again, they haven't seen what other companies are reporting. I mediate the penetration piece we're talking about is probably maybe the variable of incompatibility between the two. We're not saw that we're recession-proof ever. I mediate that's a ridiculous position to take. But what we've seen birthright now and the growth rates of what we've been experiencing, birthright now we're looking for a kindly 2019 in China.

Richard Newitter -- Leerink Partners -- Analyst

Excellent. And just if you could maybe just -- maybe you mentioned it earlier. But mandibular advancement, what's contemplated or how are you thinking about the contribution in 2019? Should they mediate of that launch benevolent of hitting the ground running birthright off the bat? Is that more of a gradual cadence? And what's contemplated in the outlook? Thanks.

Joseph M. Hogan -- President and Chief Executive Officer

I'll capture a tall level and let John capture the specific level. But, remember, MAV was just approved in November of 2018. And I await their intimate uptake in the United States, which is orthos will finish two or three cases and pickup used to it. It's a phenomenal product. It really is, I think. You straighten your teeth. You can wobble your mandible forward, in that sense, and build bone. It's just incredible. But, I mean, with something that sizable and that revolutionary, orthos are conservative anyway. And, obviously, they're gonna capture their time in the sense of proving it.

Now, MAV has been outside the United States for a while, too, so they have, I think, 17,000 cases they talked about that we've gone through. What's really interesting, too, is they fill several updates from Jelco and the engineering team on MAV also, when teeth are shorter, how you organize your liners to execute it work, making positive the wings are a lot stronger than before. So, as this is approved in the United States, they mediate we've significantly improved the product over the terminal 12 months too.

We find, too, it's just a majestic halo outcome around MAV and teen. If you start to finish more MAV, you finish more teens. And so we're looking forward to that but, again, it's current days in the United States and we'll give you updates as they evaporate through the year.

John F. Morici -- Chief monetary Officer

And so when they recognize at their forecast and they mediate about flat ASPs, this is one that helps us. This is a positive repercussion to their ASPs because it's a complete case, it's a teen case, it's complicated. like Joe said, it gives us more and more teen volume and they recognize at that as favorable fuse and favorable growth for us.

Shirley Stacy -- Vice President, Corporate Communications and Investor Relations

Okay. Well, thank you, everyone, for joining us on the convene today. They recognize forward to catching up with you at subsequent conferences and if you fill any questions, gladden contact Investor Relations. fill a majestic day.

Operator

Thank you. This concludes today's conference. You may disconnect your lines at this time and thank you for your participation.

Duration: 72 minutes

Call participants:

Shirley Stacy -- Vice President, Corporate Communications and Investor Relations

Joseph M. Hogan -- President and Chief Executive Officer

John F. Morici -- Chief monetary Officer

Robert Jones -- Goldman Sachs -- Analyst

Elizabeth Anderson -- Evercore ISI -- Analyst

Jonathan block -- Stifel, Nicolaus & Co. -- Analyst

Brandon Couillard -- Jefferies -- Analyst

Steve Beuchaw -- Morgan Stanley -- Analyst

Erin Wright -- Credit Suisse -- Analyst

Ravi Misra -- Berenberg Capital Markets -- Analyst

John Kreger -- William Blair & Co. -- Analyst

Steven Valiquette -- Barclays Capital -- Analyst

Richard Newitter -- Leerink Partners -- Analyst

More ALGN analysis

This article is a transcript of this conference convene produced for The Motley Fool. While they strive for their absurd Best, there may be errors, omissions, or inaccuracies in this transcript. As with everything their articles, The Motley Fool does not assume any responsibility for your employ of this content, and they strongly encourage you to finish your own research, including listening to the convene yourself and reading the company's SEC filings. gladden observe their Terms and Conditions for additional details, including their Obligatory Capitalized Disclaimers of Liability.

More From The Motley Fool

Motley Fool Transcription has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Align Technology. The Motley Fool has a disclosure policy.


Keystone Semiconductor to present Lowest-cost Dab Single-chip Tsunami Family Featuring coast present EPG and TPEG for German Digital Radio Marketing | killexams.com real questions and Pass4sure dumps

Hsinchu, Taiwan (PRWEB) September 13, 2011

KeyStone Semiconductor Corp. (KeyStone), a leading fabless semiconductor developer of advanced digital radio technologies announced today that its 2nd generation single-chip FM/DAB/DAB+/DMB-R receiver IC, KSW8650, offers the lowest-cost turn-key solutions to support German DAB+ coast show, EPG, and TPEG applications. Integrated with triple-band RF receiver, demodulator, DSP, micro control unit, glance memory, stereo DAC, battery detector, power management, etc, KSW8650 is the state-of-the-art digital radio IC that meets German lowest-power and lowest-cost multimedia DAB market demands.

KSW8650, based on KeyStone’s proprietary digital radio technologies, provides not only decoded AAC+ audio signal but likewise digital data to pomp coast show, to present EPG, and to support TPEG on various applications. Unlike typical DAB modules that fail to support coast show, EPG, and TPEG, KeyStone’s single-chip KSW8650 is the only low-cost and low-power digital radio single-chip that satisfies German DAB+ rich-content market demands. A live demonstration clip on German DAB+ coast present by von Michael Praetorius at IFA Berlin is available at YouTube.

KeyStone offers a chain of advanced highly integrated single-chip digital radio IC family including

  •     KSW6080 to support DSP-based FM/RDS/RBDS for Apple iOS and Android platforms,
  •     KSW8080 to support traditional FM/DAB/RDS/RBDS,
  •     KSW8290 to support current FM/DAB/DAB+/DMB/RDS/RBDS,
  •     KSW8650 to support advanced FM/DAB/DAB+/DMB/RDS/RBDS/SLS/EPG/TPEG, and
  •     KSW2280 to support host-based applications with integrated RF/demodulator circuits.
  • All KeyStone single-chip digital radio IC family is built-in with 5 pre-set EQ in Bass Boost, Jazz, Live, Vocal, and Acoustic mode to work with patented two-way wireless digital radio technologies for transceiving data such as radio station information, coast show, EPG, TPEG, etc. from Tsunami modules to Apple and Android platforms and vice versa.

    KeyStone DAB single-chip family, everything housed in a small 1.1 cm x 0.8 cm uBGA package, is world’s first DAB receiver IC to build-in multiple languages including Chinese and to support both LCM and OLED pomp at no extra cost to OEMs. Company likewise offers low-cost industry-grade DAB single-chip modules that are certified by stringent Electromagnetic Compatibility (EMC) BS EN 55022: 2006 and BS EN 55013: 2001 tests with an industry-grade temperature purview of -40 C to 85 C, which are required by in-car applications.

    Certified by Apple, KSW8650 is employed in Apple MFI products such as LINGO iRis and iMini to present DAB/DAB+ audio, coast present and EPG. LINGO products are available at German Gravis, Apple Store Europe, and authorized iStore worldwide. Newly introduced LINGO iDas is an Apple MFI docking station based on KeyStone’s patented “BigFish” technology to allow Apple idevices and Android phones to wirelessly control DAB dock stations by a free app DAB GO!. LINGO iVy is world’s first and smallest Bluetooth DAB receiver to work with smart phones.

    For more information on KeyStone’s digital radio Tsunami family, product roadmap, product applications, patented wireless digital radio technology, and chip/module quotation, gladden route your probe to contact(at)KeyStonesemi(dot)com.

    About KeyStoneKeyStone Semiconductor Corp. is a technical innovator and leader in wireless digital radio semiconductor. Company is dedicated in providing a chain of low-power and low-cost digital radio IC family for today’s multimedia broadcasting market demands. KeyStone offers turn-key solutions from novel Apple and Android apps such as DAB GO!, FM GO!, POWER GO!, KEYSTONE to complete digital radio design platforms to reduce customers’ time-to-market efforts.KeyStone products enable the delivery of the enriched analog and digital multimedia contents to home and mobile environments. Company provides the industry with the lowest-cost system-on-a-chip turn-key solutions to manufacturers of analog and digital broadcasting access products and portable devices.KeyStone is funded by public companies and private entities. Company is headquartered in the Science-Based Industrial Park, Taiwan, and has offices and facilities in North America and in China. KeyStone can be contacted at +886.3.666.2756 or at contact(at)keystonesemi(dot)com.

    Press Inquiries:

    KeyStone Semiconductor Corp.2nd Floor 62 Park Avenue 2,Science-Based Industrial Park,Hsinchu, Taiwan 300Office: +886-3-666-2756Fax: +886-3-666-2758Email: Contact(at)KeyStonesemi(dot)comWeb: http://www.KeyStonesemi.com __title__ ]

    ###

    Read the complete anecdote at http://www.prweb.com/releases/2011/9/prweb8786699.htm



    Direct Download of over 5500 Certification Exams

    3COM [8 Certification Exam(s) ]
    AccessData [1 Certification Exam(s) ]
    ACFE [1 Certification Exam(s) ]
    ACI [3 Certification Exam(s) ]
    Acme-Packet [1 Certification Exam(s) ]
    ACSM [4 Certification Exam(s) ]
    ACT [1 Certification Exam(s) ]
    Admission-Tests [13 Certification Exam(s) ]
    ADOBE [93 Certification Exam(s) ]
    AFP [1 Certification Exam(s) ]
    AICPA [2 Certification Exam(s) ]
    AIIM [1 Certification Exam(s) ]
    Alcatel-Lucent [13 Certification Exam(s) ]
    Alfresco [1 Certification Exam(s) ]
    Altiris [3 Certification Exam(s) ]
    Amazon [2 Certification Exam(s) ]
    American-College [2 Certification Exam(s) ]
    Android [4 Certification Exam(s) ]
    APA [1 Certification Exam(s) ]
    APC [2 Certification Exam(s) ]
    APICS [2 Certification Exam(s) ]
    Apple [69 Certification Exam(s) ]
    AppSense [1 Certification Exam(s) ]
    APTUSC [1 Certification Exam(s) ]
    Arizona-Education [1 Certification Exam(s) ]
    ARM [1 Certification Exam(s) ]
    Aruba [6 Certification Exam(s) ]
    ASIS [2 Certification Exam(s) ]
    ASQ [3 Certification Exam(s) ]
    ASTQB [8 Certification Exam(s) ]
    Autodesk [2 Certification Exam(s) ]
    Avaya [96 Certification Exam(s) ]
    AXELOS [1 Certification Exam(s) ]
    Axis [1 Certification Exam(s) ]
    Banking [1 Certification Exam(s) ]
    BEA [5 Certification Exam(s) ]
    BICSI [2 Certification Exam(s) ]
    BlackBerry [17 Certification Exam(s) ]
    BlueCoat [2 Certification Exam(s) ]
    Brocade [4 Certification Exam(s) ]
    Business-Objects [11 Certification Exam(s) ]
    Business-Tests [4 Certification Exam(s) ]
    CA-Technologies [21 Certification Exam(s) ]
    Certification-Board [10 Certification Exam(s) ]
    Certiport [3 Certification Exam(s) ]
    CheckPoint [41 Certification Exam(s) ]
    CIDQ [1 Certification Exam(s) ]
    CIPS [4 Certification Exam(s) ]
    Cisco [318 Certification Exam(s) ]
    Citrix [48 Certification Exam(s) ]
    CIW [18 Certification Exam(s) ]
    Cloudera [10 Certification Exam(s) ]
    Cognos [19 Certification Exam(s) ]
    College-Board [2 Certification Exam(s) ]
    CompTIA [76 Certification Exam(s) ]
    ComputerAssociates [6 Certification Exam(s) ]
    Consultant [2 Certification Exam(s) ]
    Counselor [4 Certification Exam(s) ]
    CPP-Institue [2 Certification Exam(s) ]
    CPP-Institute [1 Certification Exam(s) ]
    CSP [1 Certification Exam(s) ]
    CWNA [1 Certification Exam(s) ]
    CWNP [13 Certification Exam(s) ]
    Dassault [2 Certification Exam(s) ]
    DELL [9 Certification Exam(s) ]
    DMI [1 Certification Exam(s) ]
    DRI [1 Certification Exam(s) ]
    ECCouncil [21 Certification Exam(s) ]
    ECDL [1 Certification Exam(s) ]
    EMC [129 Certification Exam(s) ]
    Enterasys [13 Certification Exam(s) ]
    Ericsson [5 Certification Exam(s) ]
    ESPA [1 Certification Exam(s) ]
    Esri [2 Certification Exam(s) ]
    ExamExpress [15 Certification Exam(s) ]
    Exin [40 Certification Exam(s) ]
    ExtremeNetworks [3 Certification Exam(s) ]
    F5-Networks [20 Certification Exam(s) ]
    FCTC [2 Certification Exam(s) ]
    Filemaker [9 Certification Exam(s) ]
    Financial [36 Certification Exam(s) ]
    Food [4 Certification Exam(s) ]
    Fortinet [13 Certification Exam(s) ]
    Foundry [6 Certification Exam(s) ]
    FSMTB [1 Certification Exam(s) ]
    Fujitsu [2 Certification Exam(s) ]
    GAQM [9 Certification Exam(s) ]
    Genesys [4 Certification Exam(s) ]
    GIAC [15 Certification Exam(s) ]
    Google [4 Certification Exam(s) ]
    GuidanceSoftware [2 Certification Exam(s) ]
    H3C [1 Certification Exam(s) ]
    HDI [9 Certification Exam(s) ]
    Healthcare [3 Certification Exam(s) ]
    HIPAA [2 Certification Exam(s) ]
    Hitachi [30 Certification Exam(s) ]
    Hortonworks [4 Certification Exam(s) ]
    Hospitality [2 Certification Exam(s) ]
    HP [750 Certification Exam(s) ]
    HR [4 Certification Exam(s) ]
    HRCI [1 Certification Exam(s) ]
    Huawei [21 Certification Exam(s) ]
    Hyperion [10 Certification Exam(s) ]
    IAAP [1 Certification Exam(s) ]
    IAHCSMM [1 Certification Exam(s) ]
    IBM [1532 Certification Exam(s) ]
    IBQH [1 Certification Exam(s) ]
    ICAI [1 Certification Exam(s) ]
    ICDL [6 Certification Exam(s) ]
    IEEE [1 Certification Exam(s) ]
    IELTS [1 Certification Exam(s) ]
    IFPUG [1 Certification Exam(s) ]
    IIA [3 Certification Exam(s) ]
    IIBA [2 Certification Exam(s) ]
    IISFA [1 Certification Exam(s) ]
    Intel [2 Certification Exam(s) ]
    IQN [1 Certification Exam(s) ]
    IRS [1 Certification Exam(s) ]
    ISA [1 Certification Exam(s) ]
    ISACA [4 Certification Exam(s) ]
    ISC2 [6 Certification Exam(s) ]
    ISEB [24 Certification Exam(s) ]
    Isilon [4 Certification Exam(s) ]
    ISM [6 Certification Exam(s) ]
    iSQI [7 Certification Exam(s) ]
    ITEC [1 Certification Exam(s) ]
    Juniper [64 Certification Exam(s) ]
    LEED [1 Certification Exam(s) ]
    Legato [5 Certification Exam(s) ]
    Liferay [1 Certification Exam(s) ]
    Logical-Operations [1 Certification Exam(s) ]
    Lotus [66 Certification Exam(s) ]
    LPI [24 Certification Exam(s) ]
    LSI [3 Certification Exam(s) ]
    Magento [3 Certification Exam(s) ]
    Maintenance [2 Certification Exam(s) ]
    McAfee [8 Certification Exam(s) ]
    McData [3 Certification Exam(s) ]
    Medical [69 Certification Exam(s) ]
    Microsoft [374 Certification Exam(s) ]
    Mile2 [3 Certification Exam(s) ]
    Military [1 Certification Exam(s) ]
    Misc [1 Certification Exam(s) ]
    Motorola [7 Certification Exam(s) ]
    mySQL [4 Certification Exam(s) ]
    NBSTSA [1 Certification Exam(s) ]
    NCEES [2 Certification Exam(s) ]
    NCIDQ [1 Certification Exam(s) ]
    NCLEX [2 Certification Exam(s) ]
    Network-General [12 Certification Exam(s) ]
    NetworkAppliance [39 Certification Exam(s) ]
    NI [1 Certification Exam(s) ]
    NIELIT [1 Certification Exam(s) ]
    Nokia [6 Certification Exam(s) ]
    Nortel [130 Certification Exam(s) ]
    Novell [37 Certification Exam(s) ]
    OMG [10 Certification Exam(s) ]
    Oracle [279 Certification Exam(s) ]
    P&C [2 Certification Exam(s) ]
    Palo-Alto [4 Certification Exam(s) ]
    PARCC [1 Certification Exam(s) ]
    PayPal [1 Certification Exam(s) ]
    Pegasystems [12 Certification Exam(s) ]
    PEOPLECERT [4 Certification Exam(s) ]
    PMI [15 Certification Exam(s) ]
    Polycom [2 Certification Exam(s) ]
    PostgreSQL-CE [1 Certification Exam(s) ]
    Prince2 [6 Certification Exam(s) ]
    PRMIA [1 Certification Exam(s) ]
    PsychCorp [1 Certification Exam(s) ]
    PTCB [2 Certification Exam(s) ]
    QAI [1 Certification Exam(s) ]
    QlikView [1 Certification Exam(s) ]
    Quality-Assurance [7 Certification Exam(s) ]
    RACC [1 Certification Exam(s) ]
    Real-Estate [1 Certification Exam(s) ]
    RedHat [8 Certification Exam(s) ]
    RES [5 Certification Exam(s) ]
    Riverbed [8 Certification Exam(s) ]
    RSA [15 Certification Exam(s) ]
    Sair [8 Certification Exam(s) ]
    Salesforce [5 Certification Exam(s) ]
    SANS [1 Certification Exam(s) ]
    SAP [98 Certification Exam(s) ]
    SASInstitute [15 Certification Exam(s) ]
    SAT [1 Certification Exam(s) ]
    SCO [10 Certification Exam(s) ]
    SCP [6 Certification Exam(s) ]
    SDI [3 Certification Exam(s) ]
    See-Beyond [1 Certification Exam(s) ]
    Siemens [1 Certification Exam(s) ]
    Snia [7 Certification Exam(s) ]
    SOA [15 Certification Exam(s) ]
    Social-Work-Board [4 Certification Exam(s) ]
    SpringSource [1 Certification Exam(s) ]
    SUN [63 Certification Exam(s) ]
    SUSE [1 Certification Exam(s) ]
    Sybase [17 Certification Exam(s) ]
    Symantec [134 Certification Exam(s) ]
    Teacher-Certification [4 Certification Exam(s) ]
    The-Open-Group [8 Certification Exam(s) ]
    TIA [3 Certification Exam(s) ]
    Tibco [18 Certification Exam(s) ]
    Trainers [3 Certification Exam(s) ]
    Trend [1 Certification Exam(s) ]
    TruSecure [1 Certification Exam(s) ]
    USMLE [1 Certification Exam(s) ]
    VCE [6 Certification Exam(s) ]
    Veeam [2 Certification Exam(s) ]
    Veritas [33 Certification Exam(s) ]
    Vmware [58 Certification Exam(s) ]
    Wonderlic [2 Certification Exam(s) ]
    Worldatwork [2 Certification Exam(s) ]
    XML-Master [3 Certification Exam(s) ]
    Zend [6 Certification Exam(s) ]





    References :


    Dropmark : http://killexams.dropmark.com/367904/11889519
    Wordpress : http://wp.me/p7SJ6L-220
    Dropmark-Text : http://killexams.dropmark.com/367904/12866507
    Blogspot : http://killexamsbraindump.blogspot.com/2017/12/review-9a0-901-real-question-and.html
    RSS Feed : http://feeds.feedburner.com/ExactlySame9a0-901QuestionsAsInRealTestWtf
    Box.net : https://app.box.com/s/5ko65vf7z6wcoh9cbuxjauajk8y90hn9






    Back to Main Page
    About Killexams exam dumps



    www.pass4surez.com | www.killcerts.com | www.search4exams.com